Related Experiment Video
Updated: Jun 13, 2025

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
The tyrosine kinase inhibitor Nintedanib induces lysosomal dysfunctionality: Role of protonation-dependent
Elena Mosca1, Anja Federa2, Christine Pirker1
1Center of Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090, Vienna, Austria.
Abstract:
Nintedanib (NIN), a multi-tyrosine kinase inhibitor clinically approved for idiopathic pulmonary fibrosis and lung cancer, is characterized by protonation-dependent lysosomotropic behavior and appearance of lysosome-specific fluorescence emission properties. Here we investigate whether spontaneous formation of a so far unknown NIN matter within the acidic cell compartment is underlying these unexpected emissive properties and investigate the consequences on lysosome functionality. Lysosomes of cells treated with NIN, but not non-protonatable NIN derivatives, exhibited lysosome-associated birefringence signals co-localizing with the NIN-derived fluorescence emission. Sensitivity of both parameters towards vATPase inhibitors confirmed pH-dependent, spontaneous adoption of novel crystalline NIN structures in lysosomes. Accordingly, NIN crystallization from buffer solutions resulted in formation of multiple crystal polymorphs with pH-dependent fluorescence properties. Cell-free crystals grown at lysosomal-like pH conditions resembled NIN-treated cell lysosomes concerning fluorescence pattern, photobleaching dynamics, and Raman spectra. However, differences in birefringence intensity and FAIM-determined anisotropy, as well as predominant association with (intra)lysosomal membrane structures, suggested formation of a semi-solid NIN crystalline matter in acidic lysosomes. Despite comparable target kinase inhibition, NIN, but not its non-protonatable derivatives, impaired lysosomal functionality, mediated massive cell vacuolization, enhanced autophagy, deregulated lipid metabolism, and induced atypical phospholipidosis. Moreover, NIN exerted distinct phototoxicity, strictly dependent on lysosomal microcrystallization events. The spontaneous formation of NIN crystalline structures was also observable in the gut mucosa of orally NIN-treated mice. Summarizing, the here-described kinase inhibition-independent impact of NIN on lysosomal functionality mediates several of its cell biological activities and might contribute to NIN adverse effects.
Insights
Nintedanib (NIN) forms crystalline structures in acidic lysosomes, impacting cell function independently of kinase inhibition. This lysosomal microcrystallization contributes to NIN
Area of Science:
- Cell Biology
- Pharmacology
- Biophysics
Background:
- Nintedanib (NIN) is a multi-tyrosine kinase inhibitor used for idiopathic pulmonary fibrosis and lung cancer.
- NIN exhibits protonation-dependent lysosomotropic behavior and unique lysosome-specific fluorescence.
- The underlying mechanism for these properties and their impact on lysosome function remain unclear.
Purpose of the Study:
- To investigate the spontaneous formation of Nintedanib matter within acidic cellular compartments.
- To determine if this matter formation underlies NIN's emissive properties and affects lysosome functionality.
- To explore the consequences of NIN-induced lysosomal changes on cellular processes and potential adverse effects.
Main Methods:
- Cellular experiments using Nintedanib and non-protonatable derivatives.
- Analysis of lysosomal birefringence, fluorescence emission, and vATPase inhibitor sensitivity.
- In vitro crystallization of NIN under varying pH conditions, coupled with spectroscopic and microscopic analysis.
- Assessment of lysosomal functionality, autophagy, lipid metabolism, and phospholipidosis in treated cells.
- In vivo studies in mice orally treated with Nintedanib.
Main Results:
- Lysosomes treated with NIN, but not its derivatives, showed pH-dependent, spontaneous formation of crystalline NIN structures.
- These crystalline structures exhibited fluorescence and birefringence, co-localizing within lysosomes.
- Nintedanib-induced lysosomal crystallization impaired lysosomal function, caused vacuolization, enhanced autophagy, deregulated lipid metabolism, and induced phospholipidosis.
- Nintedanib also induced phototoxicity dependent on lysosomal microcrystallization.
- NIN crystalline structures were observed in the gut mucosa of treated mice.
Conclusions:
- Nintedanib spontaneously forms crystalline matter within acidic lysosomes, leading to unique emissive properties.
- This kinase inhibition-independent impact on lysosomal functionality drives several of NIN's cell biological activities.
- Lysosomal microcrystallization of Nintedanib may contribute to its observed adverse effects and phototoxicity.
Related Concept Videos
Lysosomal Hydrolases
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...

